Oragen to present ONP-002 intranasal platform at IPAC-RS 2026
Oragen said its CMO will present clinical translation of ONP-002 and intranasal delivery progress at IPAC-RS 2026. The company also said it plans an IND submission and Phase IIa progress.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.